Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.
Totus Medicines employs uses AI/ML and innovative DNA-encoded covalent library tech to discover small molecule medicines.
Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.
Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients.
CH4 Global mission is to use sustainable aquaculture to impact climate change at scale.
Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.
NILO Therapeutics is a biotechnology and therapeutics company.
AgZen develops pesticide sprays stick to plants which reduces pollution and helps farmers save.
SyntaxBio develops genetic programming platform that can program cells without the need for consistent external intervention.
Latus Bio focuses on developing innovative gene therapy candidates using precision delivery to enhance the lives of patients.
Estes Energy is a California-based startup developing advanced, U.S.-made, chemistry-agnostic battery packs for mobility and industry.
Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.
Grove Biopharma is a biotechnology company offering a materials science solution to peptide therapeutic challenges.
Solu Therapeutics Platform Company that develops antibody-based medicines using a degradable warhead.
Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines.
MycoWorks is a biotechnology company that offers non-plastic and non-animal materials to the market.
Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.
Valar Labs offers assistance services for cancer treatment through Artificial Intelligence.
Ascend Gene & Cell Therapies is a model for gene and cell therapy manufacturing.
Empirico is a developer of an insights platform designed to turn biological insights from human genetics into new medicines.
Novome Biotechnologies is a biotechnology company focused on engineering defined activities into the human.
Verdant builds AI-powered Smart Sprayers that weed, thin, fertilize & deliver nutrients at millimeter level.
Reinventing drug development from the ground up to make safe, effective oligonucleotide-based medicines possible on demand.
Stemson Therapeutics is a pre-clinical stage cell therapy company.
DCVC Bio has invested in 56 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
DCVC Bio's top investment sectors include Biotechnology, Medical, Therapeutics, Biopharma, Health Care. The firm invests across 28 different industry categories.
Among tracked funding rounds, Orca Bio received $250.0M in a Series F round. DCVC Bio's total known invested capital is $2.6B.
DCVC Bio's average investment size is $64.0M across its portfolio of 56 companies.
Recent DCVC Bio portfolio additions include GenEdit, Totus Medicines, Radionetics Oncology, Orca Bio, CH4 Global. These companies were founded in 2020 or later.